Compass Therapeutics Inc (NASDAQ:CMPX) price on Friday, April 11, rose 2.73% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.70.
A look at the stock’s price movement, the close in the last trading session was $1.65, moving within a range at $1.61 and $1.7. The beta value (5-Year monthly) was 1.187. Turning to its 52-week performance, $4.08 and $0.76 were the 52-week high and 52-week low respectively. Overall, CMPX moved -31.38% over the past month.
Compass Therapeutics Inc’s market cap currently stands at around $234.39 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CMPX is a 50% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend CMPX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CMPX’s current price about -13.71% and -35.09% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.86, while 7-day volatility ratio is 13.66% and 14.35% in the 30-day chart. Further, Compass Therapeutics Inc (CMPX) has a beta value of 1.22, and an average true range (ATR) of 0.26. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -252.94% off current price level while to achieve the yearly target high, price needs to move -252.94%. Nonetheless, investors will most likely welcome a -252.94% jump to $6 which is the analysts’ median price.
If we refocus on Compass Therapeutics Inc (NASDAQ:CMPX), historical trading data shows that trading volumes averaged 4.71 over the past 10 days and 1.79 million over the past 3 months. The company’s latest data on shares outstanding shows there are 137.82 million shares.
The 41.67% of Compass Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 38.85% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.61 million on 2025-03-14, giving us a short ratio of 5.43. The data shows that as of 2025-03-14 short interest in Compass Therapeutics Inc (CMPX) stood at 470.0 of shares outstanding, with shares short rising to 3.53 million registered in 2025-02-14. Current price change has pushed the stock 16.90% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CMPX stock continues to rise going into the next quarter.
